Development and validation of a risk prediction model for overall survival in patients with nasopharyngeal carcinoma: a prospective cohort study in China

被引:9
|
作者
Miao, Siwei [1 ]
Lei, Haike [2 ]
Li, Xiaosheng [2 ]
Zhou, Wei [2 ]
Wang, Guixue [3 ]
Sun, Anlong [2 ]
Wang, Ying [2 ]
Wu, Yongzhong [2 ]
机构
[1] Chongqing Med Univ, Sch Publ Hlth, Dept Hlth Stat, Chongqing 400016, Peoples R China
[2] Chongqing Univ, Canc Hosp, Chongqing Canc Multiom Big Data Applicat Engn Res, Chongqing 400030, Peoples R China
[3] Chongqing Univ, Coll Bioengn, MOE Key Lab Biorheol Sci & Technol, State & Local Joint Engn Lab Vasc Implants, Chongqing 400030, Peoples R China
关键词
Nasopharyngeal carcinoma; Nomogram; Overall survival; Prognosis; TO-LYMPHOCYTE RATIO; PROGNOSTIC VALUE; BIOMARKERS;
D O I
10.1186/s12935-022-02776-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Nasopharyngeal carcinoma (NPC) is prevailing in Southern China, characterized by distinct geographical distribution. Aimed to predict the overall survival (OS) of patients with nasopharyngeal carcinoma, this study developed and validated nomograms considering demographic variables, hematological biomarkers, and oncogenic pathogens in China. Methods: The clinicopathological and follow-up data of the nasopharyngeal carcinoma patients obtained from a prospective longitudinal cohort study in the Chongqing University Cancer Hospital between Jan 1, 2017 and Dec 31, 2019 (n = 1635). Cox regression model was used to tested the significance of all available variables as prognostic factors of OS. And independent prognostic factors were identified based on multivariable analysis to model nomogram. Concordance index (C-index), area under the receiver operating characteristic (AUC), calibration curve, and decision curve analysis (DCA) were measured to assess the model performance of nomogram. Results: Data was randomly divided into a training cohort (1227 observers, about 70% of data) and a validation group (408 observers, about 30% of data). At multivariable analysis, the following were independent predictors of OS in NPC patients and entered into the nomogram: age (hazard ratio [HR]: 1.03), stage (stage IV vs. stage I-II, HR: 4.54), radiotherapy (Yes vs. No, HR: 0.43), EBV (>= 1000 vs.< 1000, HR: 1.92), LAR (> 6.15 vs.<= 6.15, HR: 2.05), NLR (> 4.84 vs. <= 4.84 HR: 1.54), and PLR (> 206.33 vs.<= 206.33, HR: 1.79). The C-indexes for training cohort at 1-, 3- and 5-year were 0.73, 0.83, 0.80, respectively, in the validation cohort, the C-indexes were 0.74 (95% CI 0.63-0.86), 0.80 (95% CI 0.73-0.87), and 0.77 (95% CI 0.67-0.86), respectively. The calibration curve demonstrated that favorable agreement between the predictions of the nomograms and the actual observations in the training and validation cohorts. In addition, the decision curve analysis proved that the nomogram model had the highest overall net benefit. Conclusion: A new prognostic model to predict OS of patients with NPC was developed. This can offer clinicians treatment making and patient counseling. Furthermore, the nomogram was deployed into a website server for use.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Development and validation of a risk prediction model for overall survival in patients with nasopharyngeal carcinoma: a prospective cohort study in China
    Siwei Miao
    Haike Lei
    Xiaosheng Li
    Wei Zhou
    Guixue Wang
    Anlong Sun
    Ying Wang
    Yongzhong Wu
    Cancer Cell International, 22
  • [2] Development and validation of prediction model for overall survival in patients with lymphoma: a prospective cohort study in China
    Xiaosheng Li
    Yue Chen
    Anlong Sun
    Ying Wang
    Yao Liu
    Haike Lei
    BMC Medical Informatics and Decision Making, 23
  • [3] Development and validation of prediction model for overall survival in patients with lymphoma: a prospective cohort study in China
    Li, Xiaosheng
    Chen, Yue
    Sun, Anlong
    Wang, Ying
    Liu, Yao
    Lei, Haike
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2023, 23 (01)
  • [4] Development and validation of a risk prediction score for patients with nasopharyngeal carcinoma
    Xue, Ning
    Ou, Guoping
    Ma, Weiguo
    Jia, Lina
    Sheng, Jiahe
    Xu, Qingxia
    Liu, Yubo
    Jia, Miaomiao
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [5] Development of a nomogram for overall survival in patients with esophageal carcinoma: A prospective cohort study in China
    Yu, Shi-Shi
    Zheng, Xi
    Li, Xiao-Sheng
    Xu, Qian-Jie
    Zhang, Wei
    Liao, Zhong-Li
    Lei, Hai-Ke
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 17 (01)
  • [6] Development and validation of a risk prediction score for patients with nasopharyngeal carcinoma
    Ning Xue
    Guoping Ou
    Weiguo Ma
    Lina Jia
    Jiahe Sheng
    Qingxia Xu
    Yubo Liu
    Miaomiao Jia
    Cancer Cell International, 21
  • [7] Development and validation of a nomogram prediction model for overall survival in patients with rectal cancer
    Liang, Ling
    Li, Xiao-Sheng
    Huang, Ze-Jun
    Hu, Zu-Hai
    Xu, Qian-Jie
    Yuan, Yu-Liang
    Zhang, Wei
    Lei, Hai-Ke
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 17 (02)
  • [8] Development and validation of a nomogram model for predicting overall survival in patients with gastric carcinoma
    Liang, Guan-Zhong
    Li, Xiao-Sheng
    Hu, Zu-Hai
    Xu, Qian-Jie
    Wu, Fang
    Wu, Xiang-Lin
    Lei, Hai-Ke
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 17 (02)
  • [9] Development and external validation of a nomogram for predicting the overall survival of patients with stage II nasopharyngeal carcinoma after curative treatment
    He, Sha-Sha
    Wang, Cheng-Tao
    Peng, Zhen-Wei
    Ren, Yu-Feng
    Lu, Li-Xia
    Chen, Rui-Wan
    Liang, Shao-Bo
    Wang, Yan
    Chen, Yong
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4403 - 4412
  • [10] Development and validation of a nomogram for predicting long-term overall survival in nasopharyngeal carcinoma A population-based study
    Wu, Jiayuan
    Zhou, Quan
    Pan, Zhenyu
    Wang, Yufeng
    Hu, Liren
    Chen, Guanghua
    Wang, Shengpeng
    Lyu, Jun
    MEDICINE, 2020, 99 (04)